Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Nasdaq - Delayed Quote USD

Rydex Biotechnology Inv (RYOIX)

65.01
-0.59
(-0.90%)
At close: March 28 at 8:03:51 PM EDT
Loading Chart for RYOIX
  • Previous Close 65.60
  • YTD Return 5.15%
  • Expense Ratio 1.40%
  • Category Health
  • Last Cap Gain 50.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 92.92M
  • Beta (5Y Monthly) 0.78
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 51.00%
  • Last Dividend --
  • Inception Date Sep 1, 2004

Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Rydex Funds

Fund Family

Health

Fund Category

92.92M

Net Assets

2004-09-01

Inception Date

Performance Overview: RYOIX

View More

Trailing returns as of 3/27/2025. Category is Health.

YTD Return

RYOIX
5.15%
Category
7.95%
 

1-Year Return

RYOIX
3.48%
Category
30.16%
 

3-Year Return

RYOIX
3.52%
Category
16.10%
 

5-Year Return

RYOIX
5.26%
Category
15.71%
 

People Also Watch

Holdings: RYOIX

View More

Sector Weightings

SectorRYOIX
Healthcare   96.98%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: RYOIX

View More

Research Reports: RYOIX

View More

Top Mutual Funds